ASTRO: Standard - Dose CRT Beats Higher Dose in Stage III NSCLC
Significantly improved five - year overall survival rates with 60 Gy chemoradiation tx versus high - dose
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Oncology, Pulmonology, Radiology, Conference News, Source Type: news
More News: Cancer & Oncology | Conferences | Non-Small Cell Lung Cancer | Radiology | Respiratory Medicine